EDWARDS LIFESCIENCES CORPORATION revenue breakdown overview

EDWARDS LIFESCIENCES CORPORATION revenue for the last year amounted to 113.41 B MXN, the most of which — 85.61 B MXN — came from its highest performing source at the moment, Transcatheter Aortic Valve Replacement, the year earlier bringing 65.90 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought EDWARDS LIFESCIENCES CORPORATION 66.84 B MXN, and the year before that — 59.60 B MXN.